logo

UTMD

Utah Medical Products·NASDAQ
--
--(--)
--
--(--)

UTMD fundamentals

Utah Medical Products (UTMD) released its earnings on Jul 24, 2025: revenue was 9.95M (YoY -4.30%), beat estimates; EPS was 0.94 (YoY -4.08%), missed estimates.
Revenue / YoY
9.95M
-4.30%
EPS / YoY
0.94
-4.08%
Report date
Jul 24, 2025
EPS
Revenue

Revenue & Expenses

UTMD has released its 2025 Q3 earnings report, with revenue of 9.81M, reflecting a YoY change of -1.93%, and net profit of 2.63M, showing a YoY change of -26.16%. The Sankey diagram below clearly presents UTMD's revenue sources and cost distribution.

Key Indicators

Utah Medical Products (UTMD) key financial stats and ratios, covering profitability, financial health, and leverage.
Utah Medical Products (UTMD)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Utah Medical Products (UTMD)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Utah Medical Products (UTMD)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Utah Medical Products (UTMD) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Utah Medical Products (UTMD) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield